局部进展期食管鳞癌复发模式的预后价值:III期试验NEOCRTEC5010结果
本研究基于III期多中心前瞻性NEOCRTEC5010试验,纳入353例接受根治性食管切除术的IIB-III期食管鳞癌患者,分析复发模式对生存的影响。结果显示不同复发模式5年总生存率差异显著,早期复发者复发后生存更短,新辅助放化疗延长无病生存但复发后预后更差。
要点
- 复发者5年总生存率17.8% vs 无复发者89.2%(P<.001)。
- 早期复发者5年总生存率4.6% vs 晚期复发者51.2%(P<.001)。
- 远处转移与局部区域复发5年总生存率17.0% vs 20.0%(P=.666)。
核心结论
- 复发前原发肿瘤分期不能准确预测复发后生存,而复发模式可指导随访并预测复发后生存。
- 新辅助放化疗延长无病生存,但与复发患者(尤其是早期复发)更差的预后相关。
研究设计与样本
- III期、多中心、前瞻性NEOCRTEC5010试验纳入451例IIB-III期食管鳞癌患者,随机分为新辅助放化疗联合手术组(NCRT组)或单纯手术组(S组)并长期随访。
- 本研究分析接受根治性食管切除术患者的复发模式对生存的影响,共纳入353例患者。
主要发现
- 不同复发模式5年总生存率:复发者17.8% vs 无复发者89.2%(P<.001);早期复发者4.6% vs 晚期复发者51.2%(P<.001);远处转移者17.0% vs 局部区域复发者20.0%(P=.666)。
- 早期复发者复发后生存较晚期复发者显著缩短(HR 1.541;95%CI 1.047-2.268;P=.028)。
- 远处转移与局部区域复发患者复发后生存无显著差异(HR 1.181;95%CI 0.804-1.734;P=.396)。
- 多因素logistic分析显示pN1分期、淋巴结清扫数目<20枚和对新辅助放化疗无反应是术后早期复发的独立危险因素。
- 多因素Cox回归提示新辅助放化疗、年龄≥60岁、早期复发和pN1分期是复发后生存缩短的独立危险因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The prognosis of patients with locally advanced esophageal squamous cell carcinoma with different recurrence backgrounds is highly heterogeneous. This study aims to explore the effects of recurrence patterns on prognosis. METHODS: The phase III, multicenter, prospective NEOCRTEC5010 trial enrolled 451 patients with stage IIB-III esophageal squamous cell carcinoma randomly assigned to neoadjuvant chemoradiotherapy combined with surgery (NCRT group) or surgery alone (S group) and followed them long-term. We investigated the effects of recurrence patterns on survival in patients undergoing radical esophagectomy. RESULTS: In total, 353 patients were included in the study. The 5-year overall survival of patients with different recurrence patterns was significantly different: recurrence versus recurrence-free (17.8% vs 89.2%; P < .001), early recurrence versus late recurrence (4.6% vs 51.2%; P < .001), and distant metastasis versus locoregional recurrence (17.0% vs 20.0%; P = .666). Patients with early recurrence had significantly shorter survival after recurrence than those with late recurrence (hazard ratio, 1.541; 95% confidence interval, 1.047-2.268, P = .028). There was no significant difference in postrecurrence survival between patients with distant metastasis and locoregional recurrence (hazard ratio, 1.181; 95% confidence interval, 0.804-1.734; P = .396). Multivariate logistic analysis showed that pN1 stage, lymph node dissection <20, and lack of response to NCRT were independent risk factors for postoperative early recurrence. Multivariate Cox regression suggested that NCRT, age ≥60 years, early recurrence, and the pN1 stage were independent risk factors for shortened survival after recurrence. CONCLUSIONS: Prerecurrence primary tumor stage is inaccurate in predicting postrecurrence survival. In contrast, recurrence patterns can guide follow-up while also predicting postrecurrence survival. NCRT prolongs disease-free survival but is associated with a worse prognosis in patients with recurrence, especially early recurrence.
引用
- Chen D, Kong M, Sun J, et al. Prognostic value of recurrence pattern in locally advanced esophageal squamous cell carcinoma: Results from the phase III trial NEOCRTEC5010. J Thorac Cardiovasc Surg. 2022. PMID: 36137841. doi:10.1016/j.jtcvs.2022.08.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。